CD-19 CART therapy and orthostatic hypotension: a single center retrospective cohort study

BACKGROUND: Chimeric antigen receptor T-cell (CART) therapy is a form of cellular immunotherapy used to treat hematologic malignancies. Major adverse cardiovascular events have been seen in CART patients who have high grade CRS, higher baseline creatinine, and troponin elevation. However, the incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Ashish, Levenson, Joshua, Huang, Ziyu, Agha, Mounzer, Dorritie, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981866/
https://www.ncbi.nlm.nih.gov/pubmed/35382903
http://dx.doi.org/10.1186/s40959-022-00132-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981866/
https://www.ncbi.nlm.nih.gov/pubmed/35382903
http://dx.doi.org/10.1186/s40959-022-00132-3

Ejemplares similares